Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

By | November 24, 2022
Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.